Title : Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy.

Pub. Date : 2021

PMID : 33954150






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy. Azacitidine nuclear receptor subfamily 1 group I member 3 Homo sapiens
2 Priming leukemia cells with AZA increased CAR T cell/target cell conjugation and target cell killing, promoted CAR T cell divisions and expanded IFNgamma+ effector T cells in co-cultures with CD19+ leukemia Nalm-6 and Raji cells. Azacitidine nuclear receptor subfamily 1 group I member 3 Homo sapiens
3 Priming leukemia cells with AZA increased CAR T cell/target cell conjugation and target cell killing, promoted CAR T cell divisions and expanded IFNgamma+ effector T cells in co-cultures with CD19+ leukemia Nalm-6 and Raji cells. Azacitidine nuclear receptor subfamily 1 group I member 3 Homo sapiens
4 Conclusion: We propose that treatment with AZA activates OX40L/OX40 co-stimulatory signaling in CAR T cells. Azacitidine nuclear receptor subfamily 1 group I member 3 Homo sapiens